Related Experiment Video

Updated: May 21, 2026

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

A novel approach to the development of anticarcinogenic vaccines

A N Glushkov1, S V Apalko, M L Filipenko

  • 1Institute of Human Ecology, Siberian Branch, Russian Academy of Sciences.

Acta Naturae
|June 1, 2012
PubMed

Insights

Researchers developed a novel anticarcinogenic vaccine strategy using a benzo[a]pyrene immunomimetic peptide. This peptide, when part of a recombinant protein, specifically interacts with antibodies, paving the way for new cancer prevention methods.

Area of Science:

  • Immunology
  • Molecular Biology
  • Toxicology

Background:

  • Chemical carcinogens, such as benzo[a]pyrene, are significant contributors to cancer development.
  • Developing effective anticarcinogenic vaccines is crucial for cancer prevention.

Purpose of the Study:

  • To develop a novel approach for anticarcinogenic vaccines.
  • To select and characterize a benzo[a]pyrene immunomimetic peptide as a hapten-specific component.

Main Methods:

  • Synthesis of carcinogen-protein conjugates and antibodies against benzo[a]pyrene.
  • Phage display technology for peptide selection.
  • ELISA and molecular modeling for immunological evaluation.

Main Results:

  • A benzo[a]pyrene immunomimetic peptide was identified and incorporated into a recombinant protein with pIII sequences.
  • The recombinant protein demonstrated specific interaction with anti-benzo[a]pyrene monoclonal antibodies (mAB B2).
  • Molecular modeling elucidated the binding characteristics between mAB B2, polycyclic aromatic hydrocarbons, and the peptide.

Conclusions:

  • The study successfully identified a hapten-specific component for anticarcinogenic vaccine development.
  • A strategy for future anticarcinogenic vaccine research based on immunomimetic peptides is proposed.

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Vaccinations01:51

Vaccinations

Overview
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...